Analyst Ratings for Cue Biopharma (CUE)
CUE Rating Summary
CUE Price Target Summary
- Highest: $83.00 (B.Riley)
- Lowest: $2.00 (Citizens)
- Average: $50.33
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$50.33 (+201.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
Avg. $ Target:
$50.33 (+201.2%)
* Over Last 12-Mos
Rating Score: 10 / 10
Percentile Rank: 95%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/18/2026 | B.Riley » Updated 10/1/2026 |
Mayank Mamtani | New Coverage | Buy (N/A) |
83.00 (N/A) |
34.17 (16.71) |
-51.1% | Details |
| 8/25/2025 | Lucid Capital Markets | Dev Prasad | New Coverage | Buy (N/A) |
4.00 (N/A) |
0.83 (16.71) |
1913.25% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
